Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ru-Jun Mo"'
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-1 (2023)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-017-0615-x.
Externí odkaz:
https://doaj.org/article/d042f4c5d6534ece87fd5ad57750dda9
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-14 (2017)
Abstract Background Even though aberrant expression of microRNA (miR)-30d has been reported in prostate cancer (PCa), its associations with cancer progression remain contradictory. The aim of this study was to investigate clinical significance, biolo
Externí odkaz:
https://doaj.org/article/dafef72eefd84824ae9aabaaf94a8720
Autor:
Zhuo-yuan Lin, Guo Chen, Yan-qiong Zhang, Hui-chan He, Yu-xiang Liang, Jian-heng Ye, Ying-ke Liang, Ru-jun Mo, Jian-ming Lu, Yang-jia Zhuo, Yu Zheng, Fu-neng Jiang, Zhao-dong Han, Shu-lin Wu, Wei-de Zhong, Chin-Lee Wu
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-2 (2019)
After publication of the article [1], the author reported that this article contained some errors.
Externí odkaz:
https://doaj.org/article/d0690d58a7594798b70a58449981c3ce
Autor:
Fu-neng Jiang, Hui-chan He, Yan-qiong Zhang, Deng-Liang Yang, Jie-Hong Huang, Yun-xin Zhu, Ru-jun Mo, Guo Chen, Sheng-bang Yang, Yan-ru Chen, Wei-de Zhong, Wen-Liang Zhou
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63941 (2013)
Early diagnosis of prostate cancer (PCa), which is a clinically heterogeneous-multifocal disease, is essential to improve the prognosis of patients. However, published PCa diagnostic markers share little overlap and are poorly validated using indepen
Externí odkaz:
https://doaj.org/article/952c5f46350448748f988b03976a05f2
Autor:
Yu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, Yang-Jia Zhuo, Jian-Heng Ye, Xue-Jin Zhu, Zhou-Da Cai, Zhuo-Yuan Lin, Ru-Jun Mo, Shu-Lin Wu, Yan-Qiong Zhang, Wei-De Zhong
Publikováno v:
Disease Markers.
Background. In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV) gene was
Autor:
Zhiduan Cai, Yu Zheng, Yong Luo, Yuxiang Liang, Yangjia Zhuo, Ren Liu, Yulin Deng, Xuejin Zhu, Yingke Liang, Jianheng Ye, Jianjiang Xie, Ru-Jun Mo, Zhao-Dong Han, Weide Zhong, Yuanfa Feng, Yong-ding Wu, Chin-Lee Wu, Jianguo Zhu, Funeng Jiang
Publikováno v:
Cancer Research. 80:2150-2162
Metformin is an oral drug widely used for the treatment of type 2 diabetes mellitus. Numerous studies have demonstrated the value of metformin in cancer treatment. However, for metformin to elicit effects on cancer often requires a high dosage, and a
Autor:
Yu-Xiang, Liang, Ying-Ke, Liang, Zhi-Hao, Zou, Yang-Jia, Zhuo, Jian-Heng, Ye, Xue-Jin, Zhu, Zhou-Da, Cai, Zhuo-Yuan, Lin, Ru-Jun, Mo, Shu-Lin, Wu, Yan-Qiong, Zhang, Wei-De, Zhong
Publikováno v:
Disease markers. 2022
In our previous research, we developed a 32-gene risk index model that may be utilized as a robust prognostic method for predicting prostate cancer (PCa) recurrence after surgery. Among the 32 genes, the Fifth Ewing Variant (FEV mRNA expression was a
Autor:
Song Wan, Zhiduan Cai, Yingke Liang, Ru-Jun Mo, Jun-Xu Chen, Weide Zhong, Zhuo-yuan Lin, Ze-Zhen Liu, Zhao-Dong Han, Yulin Deng, Hui-chan He, Yangjia Zhuo
Publikováno v:
Cellular Signalling. 59:152-162
Immunotherapy has made great breakthroughs in the field of cancer. However, the immunotherapeutic effect of prostate cancer is unsatisfactory. We found that the expression of TRIB1 was significantly correlated with the infiltration of CD163+ macropha
Autor:
Yanqiong Zhang, Zhao-Dong Han, Jianheng Ye, Yingke Liang, Chin-Lee Wu, Wei-de Zhong, Sharron X. Lin, Shulin Wu, Sheng‐Da Song, Funeng Jiang, Ru-Jun Mo
Publikováno v:
International Journal of Cancer. 144:3099-3110
To investigate immune profile consisting of stromal PD-L1 expression, inhibitory or non-T-cell inflamed tumor microenvironment that may predict response to anti-PD-L1/PD-1 immunotherapy in prostate cancer, we validated the specificity of a PD-L1 mono
Autor:
Funeng Jiang, Ming Xi, Wei Hua, Ru-Jun Mo, Hong-Wei Luo, Wei-de Zhong, Yueping Wan, Yangjia Zhuo, Yulin Zhou, Zhao-Chang Zen, Yuan-Ling Liu, Hui-Chan He, Song Wan
Publikováno v:
Oncology Research and Treatment. 40:15-20
Background: Novel molecular markers are important diagnostic tools for the assessment of cancer progression and evaluation of effectiveness of the treatment. SOX9, a key regulator of developmental processes, is overexpressed in various neoplasms, suc